•  
  •  
 

Central Asian Journal of Medicine

Abstract

In December 2019 Coronavirus begin to spread first in China than COVID-19 quickly crossed whole European countries and spreads to the US, South America. Corovirus also came to Uzbekistan through Europe. COVID-19 evokes risky clinical features such as: pneumonia in the lung and acute respiratory distress syndrome which leads to breathlessness and multi organ damage. On March 11, WHO declared the COVID-19 a pandemic. Members of this virus can cause respiratory, enteric, hepatic, and neurological diseases in human body. Laboratory analysis such as decreased total white blood cell count, decreased lymphocyte count, lymphopenia, increasing of liver enzymes, C-reactive protein, Increased D-dimer were common in COVID-19 patients. Standard radiographic Imaging examination Chest X-Ray were useful for monitoring of the treatment, especially ICU care patients and patients with severe pneumonia who always on SPAP portable X – Rays were method of choice. Multi detector computed tomography very sensitive for lung changes in COVID-19 is the method of choice in the study of COVID-19 pneumonia, even in the initial stages.

First Page

119

Last Page

134

References

1. Cleo Anastassopoulou, Lucia Russo, Athanasios Tsakris. Data-based analysis, modelling and forecasting of the novel coronavirus (2019-ncov) outbreak. doi: https://doi.org/10.1101/2020.02.11.20022186. 2. Mbarka Bchetnia , Catherine Girard , Caroline Duchaine, Catherine Laprise. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. J Infect Public Health. 2020 Nov;13(11):1601-1610. 3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al.; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33. 10.1056/NEJMoa2001017 [PMC free article] [PubMed] [CrossRef] [Google Scholar]. 4. Marco Cascella; Michael Rajnik; Arturo Cuomo; Scott C. Dulebohn, Raffaela Di Napoli. Features, Evaluation, and Treatment of Coronavirus. StatPearls Publishing; 2020 Jan. 5. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, Whittaker C, Zhu H, Berah T, Eaton JW, Monod M, Imperial College COVID-19 Response Team. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 Aug; 584(7820):257-261. [PubMed] [Reference list]. 6. Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, Sanderson C, McKee M, Troeger C, Ong KL, Checchi F, Perel P, Joseph S, Gibbs HP, Banerjee A, Eggo RM. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. [PMC free article] [PubMed] [Reference list]. 7. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. Geneva, Switzerland: World Health Organization; 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 [Ref list]. 8. CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, Centers for Disease Control and Prevention. February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:382–386.[PMC free article] [PubMed] [Google Scholar]. 9. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr; 92(4):418-423. 10. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 05;172(9):577-582. 11. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2: 659–66. 12. Handbook of Health Behavior Research III: Demography, Development, and Diversity. Boston, MA: Springer US, 1997. 13. Li P., Fu J.B., Li K.F., Chen Y., Wang H.L., Liu L.J. Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster. Int J Infect Dis. 2020;96:452–453. [PMC free article][PubMed] [Google Scholar] [Ref list] 14. Backer J.A., Klinkenberg D., Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020:25.[PMC free article] [PubMed] [Google Scholar] [Ref list]. 15. Guan W.J., Zhong N.S. Clinical characteristics of Covid-19 in China. N Engl J Med. 2020;382(19):1861–1862. Reply. [PubMed] [Google Scholar] [Ref list] 16. Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, Cui Y, Fu RB, Dong YZ, Chi XY, Zhang MY, Liu K, Cao C, Liu B, Zhang K, Gao YW, Lu B, Chen W. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. 2020 Jul;26(7):1583-1591. [PMC free article] [PubMed] [Reference list] 17. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13. 10.1016/S0140-6736(20)30211-7 [PMC free article] [PubMed] [CrossRef] [Google Scholar]. 18. Team TNCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. China CDC Weekly. 2020;2 https://www.ncbi.nlm.nih.gov/pubmed/32064853 . 19. Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.Euro Surveill. 2020;25:25. 10.2807/1560-7917.ES.2020.25.3.2000044 [PMC freear ticle] [PubMed] [CrossRef] [Google Scholar]) 20. (Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014;14:480. 10.1186/1471-2334-14-480 [PMC free article] [PubMed] [CrossRef] [Google Scholar]. 21. Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–7. 10.1016/j.ijid.2020.01.050 [PMC free article][PubMed] [CrossRef] [Google Scholar]. 22. Wang Y., Wang Y., Chen Y., Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568–576. [PMC free article] [PubMed] [Google Scholar] 23. Pullano G, Pinotti F, Valdano E, Boëlle PY, Poletto C, Colizza V. Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020. Euro Surveill. 2020;25:25. 10.2807/1560-7917.ES.2020.25.4.2000057 [PMC free article] [PubMed] [CrossRef] [Google Scholar]). 24. Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25:pii–2000094. 10.2807/1560-7917.ES.2020.25.6.2000094 [PMC free article] [PubMed] [CrossRef] [Google Scholar]. 25. Recommendations for prevention, diagnosis, treatment and rehabilitation of coronavirus infection in Uzbekistan, 7-version (Covid-19) 2020. 26. Olsen SJ, Chen M-Y, Liu Y-L, Witschi M, Ardoin A, Calba C, et al. Early introduction of severe acute respiratory syndrome coronavirus 2 into Europe. Emerg Infect Dis. 2020 Jul [date cited]. https://doi.org/10.3201/eid2607.200359). 27. Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, Peccatori J, D'Angelo A, De Cobelli F, Rovere-Querini P, Tresoldi M, Dagna L, Zangrillo A. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 Apr 15;22(2):95-97. 28. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China. China CDC Weekly, 2020; 2: 1–10. 29. Kogan A, Segel MJ, Ram E, Raanani E, Peled-Potashnik Y, Levin S, Sternik L. Acute Respiratory Distress Syndrome following Cardiac Surgery: Comparison of the American-European Consensus Conference Definition versus the Berlin Definition. Respiration. 2019;97(6):518-524. [PubMed]. 30. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. [PMC free article] [PubMed]. 31. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 07;323(13):1239-1242. [PubMed]. 32. WHO Clinical management of COVID-19 interim guidance 27 May 2020 COVID-19: Clinical care. https://www.who.int/publications/i/item/clinical-management-of-covid-19. 33. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. [PMC free article] [PubMed]. 34. Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, Huang DT, Kellum JA, Mi Q, Opal SM, Talisa V, van der Poll T, Visweswaran S, Vodovotz Y, Weiss JC, Yealy DM, Yende S, Angus DC. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019 May 28;321(20):2003-2017. [PMC free article] [PubMed]. 35. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020 Jul;84:106504. [PMC free article] [PubMed]. 36. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300.[PMC free article] [PubMed]. 37. Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MTV. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019 Apr;53(4) [PubMed]. 38. Matthew Biggerstaff, Simon Cauchemez , Carrie Reed , Manoj Gambhir and Lyn Finelli. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infectious Diseases 2014, 14:480. 39. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. [PMC free article] [PubMed]. 40. Sibylle B.S., Patrick R., Yassoungo S. et.al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb 13; 25(6): 2000094.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.